| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |